Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(11%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_4
2
22%
Ph phase_3
3
33%
Ph phase_2
3
33%
Ph not_applicable
1
11%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(8)

Detailed Status

Completed8
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (33.3%)
Phase 33 (33.3%)
Phase 42 (22.2%)
N/A1 (11.1%)

Trials by Status

completed889%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_2

Triple Negative Breast Cancer and Celecoxib. Pilot Study

NCT07104266
completedphase_2

Medical Treatment of "High-Risk" Neurofibromas

NCT00846430
completedphase_3

Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.

NCT03108482
completedphase_3

Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

NCT00007189
completednot_applicable

A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

NCT01709656
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07104266Phase 2

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Recruiting
NCT00846430Phase 2

Medical Treatment of "High-Risk" Neurofibromas

Completed
NCT03108482Phase 3

Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.

Completed
NCT00007189Phase 3

Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Completed
NCT01709656Not Applicable

A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

Completed
NCT00504660Phase 2

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Completed
NCT00624559Phase 4

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

Completed
NCT00598234Phase 4

Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty

Completed
NCT00050479Phase 3

Laser and Medical Treatment of Diabetic Macular Edema

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9